Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial - The Lancet

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial  The Lancet

Comments

Popular posts from this blog

The Best Flea Treatments for Cats and Dogs

Is Citronella Safe for Dogs? A Veterinarian Provides Guidance

Everything You Need to Know About Mite and Flea Bites